Invasive Pulmonary Aspergillosis Mimicking Cyst Hydatics

Invasive pulmonary aspergillosis is a less frequent form and rarely has been reported in normal immune system cases. They do not constitute radiologi-cally cystic structures. A 53-year-old male who was engaged in stock farming and agriculture has no additional disease or habit in the patient history that would compromise the immune system. In thorax computed tomography, a 11x8x10 cm diaphragmatic invasive cystic lesion was seen in the middle and lower lobes of the right lung, It was reported that there may be hydatid cyst. The patient underwent right lower bilobectomy and diaphragm resec-tion, the diaphragm was reconstructed with a dual mesh. Histopathologic diagnosis was reported as invasive pulmonary aspergillosis. There was no complication or recurrence in the case in the 24-month follow-up period. Thus, a cure was provided for our patient with invasive pulmonary asper-gillosis, which was coincidentally diagnosed by pathology in the postoper-ative period.

___

Özyurtkuran MO, Balcı AE. Surgical treatment of intratho-racic hydatid disease: A 5 five year experience in an en-demic region. SurgToday 2010; 40: 31-37.

Lionakis MS, Kontoyiannis DP. Glucocorticoids and inva-sive fungal infections. Lancet 2003; 362: 1828–38.

Fukuda Y, Homma T, Suzuki S, et al. High burden of Aspergillus fumigatus infection among chronic respira-tory diseases. Chron Respir Dis 2018; 15(3): 279-85. doi: 10 .117 7/ 147 9 9 7 2 318 7616 5 4 .

Hope WW, Walsh TJ, Denning DW. The invasive and sap-rophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43: Suppl. 1, S207–S238.

Harmouchi H, Lakranbi M, Issoufou I, et al. Pulmonary aspergilloma: surgical outcome of 79 patients in a Moroccan center. Asian Cardiovasc Thorac Ann 2019; 6- 5: 218492319855492. doi: 10.1177/0218492319855492.

Walsh TJ, Roilides E, Cortez K, Kottilil, et al. Control, immu-no regulation, and expression of innate pulmonary host defenses agains tAspergillus fumigatus. Med Mycol 2005; 43(suppl 1): S165-72. 1, S165–S172.

Scott SM, Takaro T. Thoracic Infections Caused by Actinomycetes, Fungi, opportunistic organisms, and Echinococcus. In: Bauer AA, Geha AS, Hammond GL, et al (eds). Glenn’s Thoracic and Cardiovascular Surgery. 5th ed. SA; Prentice Hail Int. Inc, 1991: 273-5. Hail International Inc. 1991:273-5. 273-275

Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in pa-tients refractory or intolerant of conventional antifungal therapy. ClinInfectDis 2004; 39: 1563–1571.

Salerno CT, Ouyang DW, Pederson TS, et al. Surgical ther-apy for pulmonary aspergillosis in immuno compromised patients. Ann Thorac Surg 1998; 65: 1415–1419.

Reichenberger F, Habicht J, Kaim A, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic pa-tients with hematologic diseases. Am J RespirCritCareMed. 1998; 158: 885–90

Pidhorecky I, Urschel J, Anderson T. Resection of invasive pulmonary aspergillosis in immuno compromised pa-tients. AnnSurgOncol. 2000; 7: 312–17

Caillot D, Casasnovas O, Bernard A, et al. Improved man-agement of invasive pulmonary aspergillosis in neutrope-nic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139–47

Shirakusa T, Ueda H, Suito T, et al. Surgical treatment of pulmonary aspergilloma and aspergillus empyema. Ann Thorac Surg 1989, 48: 779-82.